Intelligent digital health companion for neurocognitive disorders and caregivers
Talk-to-Jo" Intelligent Digital Health Companion, Neurocognitive Disorders and Dyads: a Qualitative Study
This study is testing a digital health tool called 'Talk-to-Jo' to see if it can help older adults with neurocognitive disorders and their caregivers in Quebec feel better and manage their challenges.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal Government |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT06606353 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the use of an intelligent digital health companion, 'Talk-to-Jo', to support individuals aged 65 and older living with neurocognitive disorders (NCDs) and their caregivers. It aims to address the challenges faced by this population, particularly in Quebec, where access to primary care is often inadequate. The study will evaluate how this digital tool can improve the quality of life for patients and their caregivers by providing timely support and resources. Participants will be recruited from an outpatient clinic and must meet specific eligibility criteria, including language proficiency in French.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 65 and older diagnosed with a mild to moderate neurocognitive disorder and living with a caregiver.
Not a fit: Patients who are unable to understand spoken and written French or those living in long-term care facilities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for patients with neurocognitive disorders and their caregivers by providing accessible support and resources.
How similar studies have performed: While the use of digital health companions is a growing field, this specific approach targeting neurocognitive disorders and caregivers is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
1. Person living with an neurocognitive disorder (NCD):
1. Inclusion criteria:
* Be 65 years old or older.
* Have an NCD, whether minor or major, in a mild to moderate stage, diagnosed within the past year.
* Be receiving care for an NCD at the outpatient clinic of the Montreal Geriatric University Institute.
* Have a caregiver.
* Live in a personal residence or in a non-medicalized senior residence.
* Be able to understand spoken and written French. The "Talk-to-Jo" avatar has only been developed in the French language and can only communicate and understand French.
2. Exclusion criteria:
* Inability to provide informed consent for participation in the study.
* Participating in a concurrent experimental clinical study, to avoid interference with our study.
* Living in a Long-Term Care Facility or in a medicalized section of an non-medicalized senior residence.
* Inability to understand spoken and written French.
* Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
2. Caregiver
1. Inclusion criteria:
* Be a caregiver for a person living with an NCD (regardless of the relationship: spouse, child, friend, neighbor, family member).
* Be able to understand spoken and written French.
2. Exclusion criteria:
* Have an NCD.
* Inability to understand spoken and written French.
* Participating in a concurrent experimental clinical study, to avoid interference with our study.
* Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
Where this trial is running
Montreal, Quebec
- Criugm — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Study coordinator: Olivier Beauchet, MD
- Email: olivier.beauchet@umontreal.ca
- Phone: 5143403540
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.